Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory ...

The maker of patient monitoring devices said the incident will not have a material effect on its updated financial outlook.

IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of ...

The company will compete with a device Boston Scientific acquired for $850 million.

The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of ...

The Court of International Trade said the president overstepped his authority, halting various duties. After an appeal, the ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

The duties are slated to take effect July 9 as the bloc and the U.S. reengage on trade talks, the president said.

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions.

“For too long, Johnson & Johnson has used tying arrangements and other tactics to interfere with fair competition from ...